MetLife Inc

MetLife is one of the world's leading insurance and financial services companies. It sells life insurance, annuities (contracts that turn savings into regular income), employee benefits and asset management across the US, Asia, Latin America, Europe and the Middle East. Customers include employers, governments and other institutions and their workers, plus individuals. It earns premiums and fees, plus income from investing money set aside for future claims, mostly in bonds and mortgage loans.

Group Benefits is the biggest segment, at about 35% of 2025 revenue of $77.1 billion. It sells life, dental, disability, vision, accident and pet insurance through employers, including many of the largest US companies. Retirement and Income Solutions (RIS), about 27%, helps employers manage pension and retirement-plan promises. That includes pension risk transfers, where MetLife takes on some or all of a company's pension payments, and stable value products that keep balances steady in workplace savings plans.

Asia contributed 15.5% of revenue, Latin America nearly 11% and Europe, the Middle East and Africa about 4%. MetLife Investment Management, which runs money for institutions, became its own segment in a late-2025 reorganization and added about 1%. The rest is reported in Corporate & Other. Group Benefits results can also swing between quarters, because seasonal illnesses affect claims.

• In Q2 FY2026 (ended Jun 30, 2026), revenue was $19.15B, up 10.5% from a year earlier, and net income was $736.0M (+1.0%).
• For fiscal 2025, revenue was $77.08B (+8.6% year over year; +2.9% a year from FY2021 to FY2025) with a 4.4% net margin.

• Over FY2021–FY2025: $16.82B in buybacks and $7.85B in dividends.
• At least 9 consecutive annual increases: every fiscal year in the SEC data (FY2016–FY2025) shows an increase; the true streak may be longer.
• Regular dividends per share grew +4.3% a year over 5 years (FY2020–FY2025).
• Dividends took 44.7% of earnings in the latest fiscal year.
• Shares outstanding changed -24.5% from Oct 29, 2021 to Jul 31, 2026.

Rank among 1514 US companies

Market value at each year end

MetLife’s market value went from $59.23B at the end of 2016 to $64.15B on Nov 2, 2026, up 8%; since the end of 2025 it is up 23%.

Form 4 filings from 2025-10-27 to 2026-10-27 (25 read): 0 open-market purchases and 0 sales ($0.00).

Large shareholders (13G filings)

ETFs with the most weight in MET

1. Interest rate swings can squeeze profits. MetLife profits from the gap between what its bond-heavy portfolio earns and what it pays customers. Sharp rate rises can spur withdrawals and loss-making asset sales. Long low-rate stretches shrink that gap.
2. Losses in its large investment portfolio. A large portfolio of bonds, mortgage loans and real estate backs its promises. Defaults, downgrades or price drops could force write-downs, and some holdings may be hard to sell quickly at full value.
3. Claims could run above its estimates. Pricing and reserves (money set aside for future claims) rest on assumptions about deaths, disability, retiree lifespans and benefit use. A catastrophe, health crisis or flawed model could push claims higher.
4. A ratings downgrade could cost business. Customers judge insurers partly by financial strength ratings, agencies' grades of their ability to pay claims. A downgrade, or even the threat of one, could hurt sales and raise borrowing costs.
5. Regulators can limit cash for shareholders. The parent company depends on dividends from its insurance subsidiaries, which regulators can restrict. Tighter limits or extra cash needs could curb MetLife's own dividends and share repurchases.
6. Political and currency risks overseas. Asia (15.5% of fiscal 2025 revenue), Latin America (10.8%) and Europe, the Middle East and Africa (4.1%) carry political, legal and economic risks. Currency swings can also shrink overseas earnings in dollars.

• Sep 24, 2026 Investor presentation or announcement
• Aug 17, 2026 Other company announcement
• Aug 5, 2026 Quarterly results released; Investor presentation or announcement; Other company announcement
• Jun 29, 2026 Investor presentation or announcement
• Jun 22, 2026 Shareholder vote results
• May 15, 2026 Other company announcement
• May 6, 2026 Quarterly results released; Investor presentation or announcement; Other company announcement
• Apr 7, 2026 Investor presentation or announcement
• Mar 5, 2026 Other company announcement
• Feb 26, 2026 New debt or financial obligation; Other company announcement

MetLife has increased its dividend per share for at least 9 straight fiscal years through 2025, and the streak may be longer. The dividend grew from $1.82 in fiscal 2020 to about $2.25 in fiscal 2025, roughly 4.3% a year. Dividends paid equaled 44.7% of fiscal 2025 net income, and the yield was 2.33% as of October 28, 2026. Buybacks (share repurchases) were larger: $16.8 billion over fiscal 2021–2025, versus $7.8 billion in dividends. The share count fell 24.5% from October 2021 to July 2026.

The stock has fallen hard in crises. It dropped 82.3% in the 2008 financial crisis and took about 93 months, until December 2016, to recover. It lost 55% in the 2020 COVID crash and recovered in about 10 months. In the 2022 bear market it rose 1.2% between the market's January peak and October low, though it fell 19.4% at its worst. Single stocks carry more risk than diversified funds.